ozempic pen semaglutide Ozempic® (Semaglutide) Prefilled Injector What is Ozempic® Pen? |

Lilly's retatrutide phase 3 results: 28.3% body weight loss on highest dose May 2026 Eli Lilly's phase 3 results for retatrutide show striking efficacy in obesity treatment: 28.3% body weight loss on the highest dose over 80 weeks approximately 70 lbs on average 45% of participants lost 30% or more of their body weight 65% on the top dose were no longer clinically obese Even the lowest 4mg dose delivered 19% weight loss with fewer dropouts than placebo Retatrutide is a triple-agonist targeting GIP, GLP-1, and glucagon receptors versus one receptor for semaglutide and two for tirzepatide (Mounjaro/Zepbound)

Published retatrutide research has drawn attention because of substantial weight-related findings in trial settings

And remember this is a plan to loosely follow, but its not a strict diet. Its a lifestyle and what matters most isnt following the plan to a T

Can I dose cagrilintide in the morning if I dont eat breakfast